SAIZ is a blockchain-based token project that finances the commercialization of oral antibody treatments for viral diseases. The project operates through a licensing agreement between BioLumen and LOA BIO PHARM, a leading antibody manufacturer. SAIZ also provides AI-powered pharmaceutical market intelligence for vaccine markets, outbreak detection, and regulatory analysis.